期刊文献+

HER-2/neu基因与肿瘤 被引量:3

下载PDF
导出
摘要 肿瘤的发生发展是多阶段性、多基因参与、多种转录因子调控的过程。人类表皮生长因子受体2(human epidermal re-ceptor 2,HER-2),又名c-erbB-2基因,是一种原癌基因,编码跨膜蛋白P185HER2。HER-2/neu在调节肿瘤细胞生长、分化及存活起着重要的作用。与肿瘤的发生、转移、预后、治疗等密切相关。研究显示在乳腺癌、卵巢癌、胃癌、大肠癌、肺癌、前列腺癌中均存在不同程度的HER-2过表达。HER-2/neu基因与肿瘤的发生、发展、预后及靶点治疗成为研究的热门课题。文章针对HER-2/neu基因的结构、功能、导致肿瘤发生机制、与各种肿瘤的相关性、检测方法及靶向治疗等内容作综述。
作者 朱晓亮
出处 《南昌大学学报(医学版)》 CAS 2013年第10期96-101,共6页 Journal of Nanchang University:Medical Sciences
  • 相关文献

参考文献63

  • 1Hararid D, Yarden Y. Molecular mechanisms underlying ErbB2/ HER2 action in breast cancer[J]. Oncogene, 2000, 19 (53) : 6102-6114.
  • 2Tiseo M, Loprevite M, Ardizzoni A. Epidermal growth factor receptor inhibitors:a new prospective in the treatment of lungcancer[J]. Curr Med Chem Anticancer Agents, 2004, 4 (2): 139-148.
  • 3Slamon D J,Clark G M,Wong S G,et al. Human breast canc- er: correlation of relapse and survival with amplification of the HER-2/neu oncogene[J]. Science, 1987,235(4785) : 177-182.
  • 4Grushko T A,Blackwood M A,Schumn P L,et al. Molecular- cytogenetic analysis of HER-2/neu gene in BRCAl-associated breast cancers[J]. Cancer Res,2002,62(5) : 1481-1488. Cho H S,Mason K,Ramyar K X,et al. Structure of the extra- cellular region of HER2 alone and in complex with the Her- ceptin Fab[J]. Nature,2003,421(6924) :756-760.
  • 5Roskoski R Jr. The TrbB/HER receptor protein-tyrosine kina- ses and cancer[J]. Biochem Biophys Res Commun, 2004,319 (1) :1-11.
  • 6Tai W, Mahato R,Cheng K. The role of HER2 in cancer thera- py and targeted drug delivery[J]. J Control Release, 2010,146 (3) :264-275.
  • 7Hynes N E, MacDonald G. ErbB receptors and signaling path- ways in cancer[J]. Curr Opin Cell Biol, 2009,21(2) :177-184.
  • 8Iivanainen E, Nelimarkka L, Elenius V, et al. Angiopoietin reg- ulated recruitment of vascular smooth musele ceils by endo- thelial-derived heparin bnding EGF-like growth factor[J]. FASEB J, 2003,17 (12) : 1609-1621.
  • 9Amin D N,Campbell M R,Moasser M M. The role of HER3, the unpretentious member of the HER family,in cancer biolo- gy and cancer therapeutics[J]. Semin Cell Dev Biol, 2010,21 (9) :944-950.
  • 10Chiu C G, Masoudi H, Leung S, et al. HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patients[J]. Ann Surg,2010,251(6) :1107-1116.

二级参考文献79

共引文献84

同被引文献44

  • 1<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:164
  • 2潘贻飞,李权,卢山珊,万丽,项友群,金纯,郭贵龙.直肠癌HER-2、COX-2和血清CEA表达及三者之间的相关性研究[J].实用肿瘤杂志,2007,22(2):156-159. 被引量:4
  • 3Nunes-Xavier CE,Martín-Pérez J,Elson A,et al.Protein tyrosine phosphatases as novel targets in breast cancer therapy[J].Biochim Biophys Acta,2013,1836(2):211-226.
  • 4Sousa-Victor P,Jasper H.Epithelial regeneration and cancer:news from the Src front[J].EMBO J,2014,33(13):1423-1424.
  • 5Secord AA,Teoh DK,Barry WT,et al.A phase I trial of dasatinib,an SRC-family kinase inhibitor,in combination with paclitaxel and carboplatin in patients with advanced or recurrent ovarian cancer[J].Clin Cancer Res,2012,18(19):5489-5498.
  • 6Cartwright CA,Kamps MP,Meisler AI,et al.pp60c-src activation in human colon cancer[J].J Clin Invest,1989,83(6):2025-2033.
  • 7Irby R,Mao W,Coppola D,et al.Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential[J].Cell Growth Differ,1997,8(12):1287-1295.
  • 8Mazurenko NN,Kogan EA,Zborovskaya IB,et al.Expression of pp60c-src in human small cell and non-small cell lung carcinomas[J].Eur J Cancer,1992,28(2-3):372-377.
  • 9Lutz MP,Esser IB,Flossmann-Kast BB,et al.Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma[J].Biochem Biophys Res Commun,1998,243(2):503-508.
  • 10Kumble S,Omary MB,Cartwright CA,et al.Src activation in malignant and premalignant epithelia of Barrett′s esophagus G[J].Gastroenterology,1997,112(2):348-356.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部